Finance

Lists
1177:HKG
Sino Biopharmaceutical Ltd
HK$4.92
-2.29%
(-0.12) 1D
Aug 3, 1:49:37 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1177...
Open
HK$5.06
High
HK$5.08
Low
HK$4.88
Mkt. cap
124.82B
Avg. vol.
111.63M
Volume
33.48M
Dividend
2.03%
Quarterly dividend
HK$0.03
P/E ratio
32.62
52-wk high
HK$9.12
52-wk low
HK$4.19
EPS
HK$0.15
Shares outstanding
12.64B
No. of employees
17K
Open
HK$5.06
High
HK$5.08
Low
HK$4.88
Mkt. cap
124.82B
Avg. vol.
111.63M
Volume
33.48M
Dividend
2.03%
Quarterly dividend
HK$0.03
P/E ratio
32.62
52-wk high
HK$9.12
52-wk low
HK$4.19
EPS
HK$0.15
Shares outstanding
12.64B
No. of employees
17K
News stories
From sources across the web
Profile
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world. Intuitive Surgical first appeared on the Fortune 500 in 2024 at number 497; in 2025 the company rose to number 459 overall and ranked 43rd within the healthcare sector. Wikipedia
About Sino Biopharmaceutical Ltd
CEODavid J. Rosa
Employees17K
Founded1995
HeadquartersSunnyvale, California, United States
SectorMedical device
Websiteintuitive.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SGD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
6.81%
0.93%
0.93%
50.89%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps